HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cees G M Kallenberg Selected Research

Myeloblastin (Proteinase 3)

10/2014Advances in pathogenesis and treatment of ANCA-associated vasculitis.
4/2014Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.
12/2013Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
7/2011Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis.
3/2011Pathogenesis of ANCA-associated vasculitides.
12/2010Pathophysiology of ANCA-associated small vessel vasculitis.
9/2009Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.
5/2009Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
10/2007Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.
12/2006Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Cees G M Kallenberg Research Topics

Disease

42Vasculitis (Vasculitides)
01/2016 - 01/2002
37Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2016 - 11/2004
20Inflammation
11/2015 - 01/2002
20Wegener Granulomatosis (Wegener's Granulomatosis)
04/2015 - 02/2002
19Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2014 - 04/2002
15Microscopic Polyangiitis
04/2015 - 02/2002
12Glomerulonephritis
11/2015 - 01/2002
9Autoimmune Diseases (Autoimmune Disease)
12/2015 - 10/2003
8Systemic Vasculitis
01/2016 - 12/2006
8Rheumatoid Arthritis
01/2011 - 02/2004
5Churg-Strauss Syndrome (Allergic Angiitis)
01/2013 - 02/2002
5Human Influenza (Influenza)
11/2011 - 04/2007
4Infection
12/2013 - 02/2009
4Lupus Nephritis
04/2013 - 09/2008
4Proteinuria
01/2013 - 01/2011
3Ankylosing Spondylitis
05/2012 - 01/2011
3Necrosis
11/2011 - 06/2004
3Anoxia (Hypoxia)
01/2010 - 06/2007
3Tic Disorders (Tic Disorder)
06/2007 - 08/2003
2Giant Cell Arteritis (Horton Disease)
11/2015 - 01/2015
2Takayasu Arteritis (Arteritis, Takayasu's)
11/2015 - 01/2015
2Purpura
11/2015 - 05/2010
2Systemic Scleroderma (Systemic Sclerosis)
01/2014 - 07/2009
2Atherosclerosis
01/2014 - 09/2010
2Granuloma
12/2013 - 02/2009
2Arthritis (Polyarthritis)
05/2012 - 01/2011
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2011 - 01/2009
2Hemorrhage
06/2011 - 07/2010
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2010 - 07/2003
2Tics (Tic)
06/2007 - 04/2004
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
11/2015
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2015
1Fibrosis (Cirrhosis)
01/2014
1Carotid Artery Diseases
01/2014
1Sjogren's Syndrome (Sjogren Syndrome)
01/2013
1Rheumatic Diseases (Rheumatism)
11/2012
1Chronic Kidney Failure (Chronic Renal Failure)
06/2012
1Disease Progression
05/2012
1Critical Illness (Critically Ill)
01/2012
1Vascular System Injuries
12/2011
1Acute Kidney Injury (Acute Renal Failure)
06/2011
1Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
06/2011

Drug/Important Bio-Agent (IBA)

50Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2016 - 01/2002
22AutoantibodiesIBA
01/2016 - 02/2002
20Myeloblastin (Proteinase 3)IBA
10/2014 - 01/2002
16glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2016 - 07/2003
14rituximab (Mabthera)FDA Link
01/2016 - 01/2010
12Peroxidase (Myeloperoxidase)IBA
10/2014 - 02/2002
7HMGB1 Protein (HMG1)IBA
12/2015 - 01/2011
7Biological Markers (Surrogate Marker)IBA
07/2015 - 01/2008
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2015 - 07/2010
6AntibodiesIBA
12/2013 - 09/2008
5Complement System Proteins (Complement)IBA
11/2015 - 05/2010
5Azathioprine (Imuran)FDA LinkGeneric
04/2015 - 08/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 08/2005
4Advanced Glycosylation End ProductsIBA
01/2014 - 01/2010
3CytokinesIBA
01/2014 - 06/2005
3Influenza Vaccines (FluMist)IBA
08/2010 - 04/2007
3Immunoglobulins (Immunoglobulin)IBA
05/2010 - 02/2009
3Interleukin-17 (Interleukin 27)IBA
01/2010 - 07/2008
2CreatinineIBA
04/2015 - 01/2013
2Prednisone (Sone)FDA LinkGeneric
04/2015 - 08/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2015 - 01/2002
2ChemokinesIBA
01/2014 - 11/2004
2Idiopathic pulmonary hypertensionIBA
01/2014 - 12/2009
2Interferon Type IIBA
01/2014 - 01/2014
2Silicon Dioxide (Sand)FDA LinkGeneric
12/2013 - 03/2010
2Proteins (Proteins, Gene)IBA
08/2013 - 12/2007
2AutoantigensIBA
02/2013 - 10/2003
2GlucocorticoidsIBA
11/2012 - 07/2010
2C-Reactive ProteinIBA
01/2011 - 06/2007
2Antigen-Antibody Complex (Immune Complex)IBA
05/2010 - 10/2003
2Transcription Factors (Transcription Factor)IBA
01/2010 - 06/2007
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
05/2009 - 06/2007
2E-SelectinIBA
03/2008 - 10/2005
2Tissue Inhibitor of Metalloproteinase-1IBA
12/2007 - 06/2004
2Matrix MetalloproteinasesIBA
12/2007 - 06/2004
2Fc gamma receptor IIAIBA
07/2003 - 05/2002
1ProteomeIBA
01/2014
1Blood Proteins (Serum Proteins)IBA
08/2013
1Edetic Acid (EDTA)FDA Link
11/2012
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2012
1Angiopoietin-2IBA
01/2012
1InterleukinsIBA
11/2011
1InterferonsIBA
11/2011
1Immunoglobulin M (IgM)IBA
10/2011
1CryoglobulinsIBA
10/2011
1Rheumatoid FactorIBA
10/2011
1TNFR-Fc fusion protein (etanercept)FDA Link
08/2011
1Rapidly progressive glomerulonephritis with pulmonary hemorrhageIBA
06/2011
1Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric
05/2011
1Bacterial DNAIBA
04/2011
1interleukin-21 (interleukin 21)IBA
01/2011
1Complement C3 (C3 Complement)IBA
01/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2011
1Chemokine ReceptorsIBA
01/2011

Therapy/Procedure

4Remission Induction
04/2015 - 07/2010
1Transplants (Transplant)
11/2012
1Aftercare (After-Treatment)
12/2011
1Retreatment
10/2011